Literature DB >> 23054364

Patient selection criteria for blastocyst transfers in extended embryo culture programs.

Daniela Paes Almeida Ferreira Braga1, Amanda S Setti, Rita de Cássia S Figueira, Rogério Bonassi Machado, Assumpto Iaconelli, Edson Borges.   

Abstract

PURPOSE: To identify the correlation between different cycles, patient factors and blastocyst characteristics.
METHODS: The study included 420 patients undergoing ICSI cycles and 2781 graded blastocysts, which took into account the blastocyst quality. The correlations between the blastocyst parameters and the patient and cycle characteristics were assessed.
RESULTS: The blastocyst development was negatively correlated with the maternal age, BMI and dose of FSH. The ICM was negatively correlated with the FSH dose, whereas the TE quality was influenced by the FSH dose, the maternal age and the number of retrieved oocytes. The embryo morphology on days two and three may predict the blastocyst developmental competence.
CONCLUSIONS: Older patients and patients with high BMI should not be included in extended embryo culture programmes. The extended culture may not favour embryos with poor morphology on days two and three of development. Additionally, a lower ovarian stimulation and decreased oocyte yields may lead to the development of high-quality blastocysts.

Entities:  

Mesh:

Year:  2012        PMID: 23054364      PMCID: PMC3528882          DOI: 10.1007/s10815-012-9875-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  48 in total

1.  Comparison of in-vitro development of embryos originating from either conventional in-vitro fertilization or intracytoplasmic sperm injection.

Authors:  J C Dumoulin; E Coonen; M Bras; L C van Wissen; R Ignoul-Vanvuchelen; J M Bergers-Jansen; J G Derhaag; J P Geraedts; J L Evers
Journal:  Hum Reprod       Date:  2000-02       Impact factor: 6.918

2.  Day 3 morphology is a poor predictor of blastocyst quality in extended culture.

Authors:  J Graham; T Han; R Porter; M Levy; R Stillman; M J Tucker
Journal:  Fertil Steril       Date:  2000-09       Impact factor: 7.329

3.  Morphological evaluation of human embryos and derivation of an embryo quality scoring system specific for day 3 embryos: a preliminary study.

Authors:  N N Desai; J Goldstein; D Y Rowland; J M Goldfarb
Journal:  Hum Reprod       Date:  2000-10       Impact factor: 6.918

4.  Routine blastocyst culture and transfer: 201 patients' experience.

Authors:  Y Y Hsieh; H D Tsai; F C Chang
Journal:  J Assist Reprod Genet       Date:  2000-09       Impact factor: 3.412

Review 5.  Blastocyst versus day 2 or 3 transfer.

Authors:  W B Schoolcraft; D K Gardner
Journal:  Semin Reprod Med       Date:  2001-09       Impact factor: 1.303

6.  The effect of intracytoplasmic sperm injection and semen parameters on blastocyst development in vitro.

Authors:  J E Miller; T T Smith
Journal:  Hum Reprod       Date:  2001-05       Impact factor: 6.918

7.  Extended embryo culture in human assisted reproduction treatments.

Authors:  M T Langley; D M Marek; D K Gardner; K M Doody; K J Doody
Journal:  Hum Reprod       Date:  2001-05       Impact factor: 6.918

8.  Influence of patient age on the growth and transfer of blastocyst-stage embryos.

Authors:  Bruce S Shapiro; Kevin S Richter; Dee C Harris; Said T Daneshmand
Journal:  Fertil Steril       Date:  2002-04       Impact factor: 7.329

9.  Integration of blastocyst transfer for all patients.

Authors:  Michael Wilson; Kathy Hartke; Michelle Kiehl; Jonetta Rodgers; Celeste Brabec; Rodney Lyles
Journal:  Fertil Steril       Date:  2002-04       Impact factor: 7.329

10.  A controlled randomized trial evaluating the effect of lowered incubator oxygen tension on live births in a predominantly blastocyst transfer program.

Authors:  Marius Meintjes; Samuel J Chantilis; James D Douglas; Alfred J Rodriguez; Ali R Guerami; David M Bookout; Brian D Barnett; James D Madden
Journal:  Hum Reprod       Date:  2008-10-16       Impact factor: 6.918

View more
  6 in total

1.  Should the flexibility enabled by performing a day-4 embryo transfer remain as a valid option in the IVF laboratory? A systematic review and network meta-analysis.

Authors:  M Simopoulou; K Sfakianoudis; P Tsioulou; A Rapani; E Maziotis; P Giannelou; S Grigoriadis; A Pantou; K Nikolettos; N Vlahos; K Pantos; M Koutsilieris
Journal:  J Assist Reprod Genet       Date:  2019-05-20       Impact factor: 3.412

2.  Is the presence of an uncleaved embryo on day 3 a useful predictor of outcomes following day 5 transfer?

Authors:  Clara J Men; Charles L Bormann; Brian W Walsh; Catherine Racowsky
Journal:  J Assist Reprod Genet       Date:  2015-07-24       Impact factor: 3.412

3.  Protein expression in human cumulus cells as an indicator of blastocyst formation and pregnancy success.

Authors:  Daniela Paes Almeida Ferreira Braga; Amanda Souza Setti; Edson Guimarães Lo Turco; Fernanda Bertuccez Cordeiro; Elaine Cristina Cabral; Sylvia Sanches Cortezzi; Erika Ono; Rita Cássia Sávio Figueira; Marcos Nogueira Eberlin; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2016-09-10       Impact factor: 3.412

4.  The importance of the cleavage stage morphology evaluation for blastocyst transfer in patients with good prognosis.

Authors:  Daniela P A F Braga; Amanda S Setti; Rita C S Figueira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2014-06-04       Impact factor: 3.412

5.  Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses.

Authors:  Rosane S Rodrigues; Amanda S Setti; Daniela P A F Braga; Fernanda M Valente; Assumpto Iaconelli; Edson Borges
Journal:  JBRA Assist Reprod       Date:  2014-06-27

6.  Estimating the causal effect of embryo transfer day on clinical in vitro fertilization outcomes using propensity score matching.

Authors:  Han-Chih Hsieh; Chun-I Lee; En-Yu Lai; Jia-Ying Su; Yi-Ting Huang; Wei-Lin Zheng; Chien-Hong Chen; Chun-Chia Huang; Pin-Yao Lin; Maw-Sheng Lee; Mark Liu; Yen-Tsung Huang
Journal:  BMC Pregnancy Childbirth       Date:  2021-08-13       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.